ROBERT GRILLO: Open Payments
NPI 1770565566 · GROTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 9 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $260 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: Auvelity, COBENFY, REXULTI, INGREZZA, INVEGA SUSTENNA, CAPLYTA, FANAPT.
Industry payments across CT — which companies pay providers there.
